Kimball Electronics announces rebrand as part of 65-year celebration

Last Friday, as Kimball Electronics, Inc. executives gathered to cut the ribbon on the company’s newest manufacturing facility, they also celebrated the company’s rebranding as Kimball Solutions in 2026.

In January, Kimball announced its intention to rebrand as Kimball Solutions as it celebrates 65 years of excellence and leadership in the Electronics Manufacturing Services (EMS) and Contract Manufacturing Organization (CMO) industry.

The company will launch the rebrand in a phased rollout across subsidiaries in its global footprint, beginning in July 2026, subject to necessary corporate and regulatory approvals at each location. The parent entity intends to change its name to Kimball Solutions, Inc., subject to approval by Kimball’s share owners.

“As we celebrate 65 years of excellence, we are excited to embrace our future as Kimball Solutions,” said Richard D. Phillips, Chief Executive Officer. “The rebrand reflects our expanded portfolio of capabilities and solutions-driven approach, designed to meet the complex needs of our customers. This name change, along with the recent investments in our new medical facility in Indianapolis, demonstrates our commitment to innovation and the vision to deliver comprehensive solutions for customers worldwide. While the name of the company is changing, our core values of integrity, quality, and continuous improvement remain steadfast. These steps are a celebration of our heritage and a bold step toward the future – Building Tomorrow, Together.”

“We are proud of our new Kimball Solutions medical facility and the manufacturing capabilities and capacity that it will add in Indianapolis,” Randy Sible, General Manager at the Indianapolis facility, added. “This investment is representative of our dedication to growth and will provide opportunity for our customers, employees, and the community.”

Second Quarter 2026 Highlights

On Feb. 4, the company reported second-quarter revenue of $341.3 million and raised its fiscal 2026 guidance, driven by 15% year-over-year growth in its medical vertical.

The Nasdaq-listed company posted results for the quarter ended Dec. 31, 2025, showing a 5% revenue decrease compared to the same period in fiscal 2025. However, adjusted operating income improved to 4.5% of net sales, up 80 basis points year-over-year.

“I’m pleased with the results for the second quarter and our updated guidance for fiscal 2026,” says Richard D. Phillips, chief executive officer. “Sales in Q2 were in line with expectations, highlighted by another quarter of strong double-digit year-over-year growth in the medical vertical. Margins improved compared to the same period last year, and cash from operations was positive for the eighth consecutive quarter.”

The company generated $6.9 million in cash from operations, marking its eighth consecutive quarter of positive operating cash flow. Operating income reached $10.8 million, or 3.2% of net sales. They also invested $4.3 million to repurchase 149,000 shares of common stock during the quarter. The company ended the quarter with $154.2 million in debt and $285.1 million in borrowing capacity.

Phillips says the company is focusing on medical manufacturing.

“Our focus as a medical CMO continues to gain momentum as we leverage our unique capabilities in the industry,” he says. “We expect top-line growth in medical to outpace our other two verticals as we balance our portfolio across the markets we serve. Our recent announcement to rebrand as Kimball Solutions, and the grand opening of the new medical manufacturing facility in Indianapolis, reflects this strategy and our expanded offering of capabilities and services.”